Comparison of Three Different Surgical Approaches on the Functional Outcome After Total Hip Arthroplasty

November 19, 2023 updated by: Antea Buterin, Clinic for Orthopedics Lovran

This study aimed to determine differences in functional recovery after total hip arthroplasty between a group of patients operated on using a direct lateral approach, an anterolateral minimally invasive approach, and a posterior approach to the hip joint.

Arthroplasty is the most commonly performed surgical procedure in orthopedics and is also considered the gold standard for treating the final stage of osteoarthritis. There are several different approaches, but there are still conflicting studies that talk about the benefits of a particular approach. There is an insufficient number of scientific, prospective studies that monitor the basic functional and rehabilitation parameters, which are also indicators of the success of the performed procedure.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Croatia
    • Primorsko-Goranska
      • Lovran, Primorsko-Goranska, Croatia, 51145
        • Recruiting
        • Clinic for Orthopeadics and Traumatology Lovran
        • Contact:
        • Principal Investigator:
          • Antea Buterin, MD
        • Principal Investigator:
          • Sandra Spanja Prpic, mag.physiotherap.
        • Principal Investigator:
          • Mirela Vuckovic, mag.physiotherap.
        • Principal Investigator:
          • Tomislav Prpic, PhD, MD, Assist. Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • hip osteoarthritis

Exclusion Criteria:

  • N/A

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Functional Recovery
Other: Functional recovery analysis
Functional recovery analysis with force evaluator & tester

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional recovery after total hip arthroplasty / Range of motion
Time Frame: 2 years
Investigators analyze active and passive range of motion (ROM) measured in degrees.
2 years
Functional recovery after total hip arthroplasty / Walking speed
Time Frame: 2 years
Investigators analyze walking speed in seconds for the 50 meters long walk.
2 years
Functional recovery after total hip arthroplasty / Harris Hip Score
Time Frame: 2 years
Investigators take a questionnaire (Harris Hip Score, HHS), the maximum point is 100.
2 years
Functional recovery after total hip arthroplasty / Hip abductors strength
Time Frame: 2 years
Investigators analyze hip abductors strength measured with a dynamometer in kilograms (kg).
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Clinic for Orthopedics Lovran

Collaborators

Special Hospital for Orthopedics Biograd na Moru

Investigators

  • Principal Investigator: Antea Buterin, MD, Clinic OL

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

February 20, 2023

First Submitted That Met QC Criteria

November 19, 2023

First Posted (Actual)

November 21, 2023

Study Record Updates

Last Update Posted (Actual)

November 21, 2023

Last Update Submitted That Met QC Criteria

November 19, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Clinic OL

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe